Tunable control of B. infantis abundance and gut metabolites by co-administration of human milk oligosaccharides

References

• U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and Control Information; Guidance for Industry. Silver Spring, MD; 2016. https://www.regulations.gov/docket/FDA-2010-D-0500.
   Google Scholar
• Cordaillat-Simmons M, Rouanet A, Pot B. Live biotherapeutic products: the importance of a defined regulatory framework. Experimental & Molecular Medicine. 2020;52(9):1397–16. doi:10.1038/s12276-020-0437-6.
   PubMed Web of Science ®Google Scholar
• Aggarwala V, Mogno I, Li Z, Yang C, Britton GJ, Chen-Liaw A, Mitcham J, Bongers G, Gevers D, Clemente JC. et al. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes. Nat Microbiol. 2021;6(10):1309–1318. doi:10.1038/s41564-021-00966-0.
   PubMed Web of Science ®Google Scholar
• Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS. et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med. 2022;386(3):220–229. doi:10.1056/NEJMoa2106516.
   PubMed Web of Science ®Google Scholar
• Danne C, Rolhion N, Sokol H. Recipient factors in faecal microbiota transplantation: one stool does not fit all. Nat Rev Gastroenterol Hepatol. 2021;18(7):503–513. doi:10.1038/s41575-021-00441-5.
   PubMed Web of Science ®Google Scholar
• Maldonado-Gómez MX, Martínez I, Bottacini F, O’Callaghan A, Ventura M, van Sinderen D, Hillmann B, Vangay P, Knights D, Hutkins RW. et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host & Microbe. 2016;20(4):515–526. doi:10.1016/j.chom.2016.09.001.
   PubMed Web of Science ®Google Scholar
• Smillie CS, Sauk J, Gevers D, Friedman J, Sung J, Youngster I, Hohmann EL, Staley C, Khoruts A, Sadowsky MJ. et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host & Microbe. 2018;23(2):229–240.e5. doi:10.1016/j.chom.2018.01.003.
   PubMed Web of Science ®Google Scholar
• Alander M, Mättö J, Kneifel W, Johansson M, Kögler B, Crittenden R, Mattila-Sandholm T, Saarela M. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Dairy J. 2001;11(10):817–825. doi:10.1016/S0958-6946(01)00100-5.
   Web of Science ®Google Scholar
• Charbonneau D, Gibb RD, Quigley EMM. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes. 2013;4(3):201–211. doi:10.4161/gmic.24196.
   PubMed Web of Science ®Google Scholar
• Firmesse O, Mogenet A, Bresson J-L, Corthier G, Furet J-P. Lactobacillus rhamnosus R11 Consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction. J Mol Microbiol Biotechnol. 2008;14(1–3):90–99. doi:10.1159/000106087.
   PubMed Web of Science ®Google Scholar
• Frese SA, Hutkins RW, Walter J. Comparison of the colonization ability of autochthonous and allochthonous strains of lactobacilli in the human gastrointestinal tract. Adv Microbiol. 2012;2(03):399–409. doi:10.4236/aim.2012.23051.
   Google Scholar
• Malinen E, Matto J, Salmitie M, Alander M, Saarela M, Palva A. PCR-ELISAII: analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis bb-12 and a galacto-oligosaccharide preparation. Syst Appl Microbiol. 2002;25(2):249–258. doi:10.1016/S0723-2020(04)70109-5.
   PubMed Web of Science ®Google Scholar
• Rattanaprasert M, Roos S, Hutkins RW, Walter J. Quantitative evaluation of synbiotic strategies to improve persistence and metabolic activity of Lactobacillus reuteri DSM 17938 in the human gastrointestinal tract. J Funct Foods. 2014;10:85–94. doi:10.1016/j.jff.2014.05.017.
   Web of Science ®Google Scholar
• Rochet V, Rigottier-Gois L, Levenez F, Cadiou J, Marteau P, Bresson J-L, Goupil-Feillerat N, Doré J. Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001 Rif. Can J Microbiol. 2008;54(8):660–667. doi:10.1139/W08-050.
   PubMed Web of Science ®Google Scholar
• Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik R-Z. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174(6):1388–1405.e21. doi:10.1016/j.cell.2018.08.041.
   PubMed Web of Science ®Google Scholar
• Louie T, Golan Y, Khanna S, Bobilev D, Erpelding N, Fratazzi C, Carini M, Menon R, Ruisi M, Norman JM. et al. VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial. JAMA. 2023;329(16):1356. doi:10.1001/jama.2023.4314.
   PubMed Web of Science ®Google Scholar
• Wong AC, Levy M. New approaches to microbiome-based therapies. mSystems. 2019;4:e00122–19. doi:10.1128/mSystems.00122-19.
   PubMed Web of Science ®Google Scholar
• Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol. 2017;35:8–15. doi:10.1016/j.mib.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205–208. doi:10.1038/nature13828.
   PubMed Web of Science ®Google Scholar
• Staley C, Kelly CR, Brandt LJ, Khoruts A, Sadowsky MJ, Blaser MJ. Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation. mBio. 2016;7(6):e01965–16. doi:10.1128/mBio.01965-16.
   PubMed Web of Science ®Google Scholar
• Frese SA, Hutton AA, Contreras LN, Shaw CA, Palumbo MC, Casaburi G, Xu G, Davis JCC, Lebrilla CB, Henrick BM. et al. Persistence of supplemented Bifidobacterium longum subsp infantis EVC001 in breastfed infants. Infantis. 2017;2(6):e00501–17. doi:10.1128/mSphere.00501-17. EVC001 in Breastfed Infants. mSphere 2017.
   Google Scholar
• Henrick BM, Rodriguez L, Lakshmikanth T, Pou C, Henckel E, Arzoomand A, Olin A, Wang J, Mikes J, Tan Z. et al. Bifidobacteria-mediated immune system imprinting early in life. Cell. 2021;184(15):3884–3898.e11. doi:10.1016/j.cell.2021.05.030.
   PubMed Web of Science ®Google Scholar
• Dsouza M, Menon R, Crossette E, Bhattarai SK, Schneider J, Kim Y-G, Reddy S, Caballero S, Felix C, Cornacchione L. et al. Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers. Cell Host & Microbe. 2022;30(4):583–598.e8. doi:10.1016/j.chom.2022.03.016.
   PubMed Web of Science ®Google Scholar
• Deehan EC, Yang C, Perez-Muñoz ME, Nguyen NK, Cheng CC, Triador L, Zhang Z, Bakal JA, Walter J. Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell Host & Microbe. 2020;27(3):389–404.e6. doi:10.1016/j.chom.2020.01.006.
   PubMed Web of Science ®Google Scholar
• Chopra T, Hecht G, Tillotson G. Gut microbiota and microbiota-based therapies for Clostridioides difficile infection. Front Med. 2023;9:1093329. doi:10.3389/fmed.2022.1093329.
   Web of Science ®Google Scholar
• Renardy M, Prokopienko AJ, Maxwell JR, Flusberg DA, Makaryan S, Selimkhanov J, Vakilynejad M, Subramanian K, Wille L. A quantitative systems pharmacology model describing the cellular kinetic‐pharmacodynamic relationship for a live biotherapeutic product to support microbiome drug development. Clin Pharma And Therapeutics. 2023;114(3):633–643. doi:10.1002/cpt.2952.
   PubMed Web of Science ®Google Scholar
• Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB. et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A. 2008;105(48):18964–18969. doi:10.1073/pnas.0809584105.
   PubMed Web of Science ®Google Scholar
• Sela DA, Garrido D, Lerno L, Wu S, Tan K, Eom H-J, Joachimiak A, Lebrilla CB, Mills DA. Bifidobacterium longum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides. Appl Environ Microbiol. 2012;78(3):795–803. doi:10.1128/AEM.06762-11.
   PubMed Web of Science ®Google Scholar
• Garrido D, Kim JH, German JB, Raybould HE, Mills DA, Uversky V. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PloS ONE. 2011;6(3):e17315. doi:10.1371/journal.pone.0017315.
   PubMed Web of Science ®Google Scholar
• Button JE, Autran CA, Reens AL, Cosetta CM, Smriga S, Ericson M, Pierce JV, Cook DN, Lee ML, Sun AK. et al. Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics. Cell Host & Microbe. 2022;30(5):712–725.e7. doi:10.1016/j.chom.2022.04.001.
   PubMed Web of Science ®Google Scholar
• Button JE, Cosetta CM, Reens AL, Brooker SL, Rowan-Nask AD, Lavin RC, Saur R, Zheng S, Autran CA, Lee ML. et al. Precision modulation of dysbiotic microbiomes with a synbiotic of human milk sugars and B. infantis reshapes gut microbial composition and metabolites; [Manuscript in press]. Cell Host Microbe:2023p. 31.
   Google Scholar
• Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: a systematic review and pooled proportion meta-analysis. JCM. 2021;10(5):959. doi:10.3390/jcm10050959.
   Google Scholar
• Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, Slingerland JB, Beghi S, Herrera PS, Giardina P. et al. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med. 2022;28(4):713–723. doi:10.1038/s41591-022-01702-9.
   PubMed Web of Science ®Google Scholar
• Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 2020;382(9):822–834. doi:10.1056/NEJMoa1900623.
   PubMed Web of Science ®Google Scholar
• Lawley B, Munro K, Hughes A, Hodgkinson AJ, Prosser CG, Lowry D, Zhou SJ, Makrides M, Gibson RA, Lay C. et al. Differentiation of Bifidobacterium longum subspecies longum and infantis by quantitative PCR using functional gene targets. PeerJ. 2017;5:e3375. doi:10.7717/peerj.3375.
   PubMed Web of Science ®Google Scholar
• Laursen MF, Sakanaka M, von Burg N, Mörbe U, Andersen D, Moll JM, Pekmez CT, Rivollier A, Michaelsen KF, Mølgaard C. et al. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat Microbiol. 2021;6(11):1367–1382. doi:10.1038/s41564-021-00970-4.
   PubMed Web of Science ®Google Scholar
• Flannigan KL, Nieves KM, Szczepanski HE, Serra A, Lee JW, Alston LA, Ramay H, Mani S, Hirota SA. The pregnane X receptor and indole-3-propionic acid shape the intestinal mesenchyme to restrain inflammation and fibrosis. Cell Mol Gastroenterol Hepatol. 2022;15(3):S765–795. doi:10.1016/j.jcmgh.2022.10.014.
   PubMed Web of Science ®Google Scholar
• Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA. et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551(7682):648–652. doi:10.1038/nature24661.
   PubMed Web of Science ®Google Scholar
• Dubberke ER, Lee CH, Orenstein R, Khanna S, Hecht G, Gerding DN. Results from a randomized, placebo-controlled clinical trial of a RBX2660—A microbiota-based drug for the prevention of recurrent Clostridium difficile infection. Clin Infect Dis. 2018;67(8):1198–1204. doi:10.1093/cid/ciy259.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med Available from. 2009;1(6). [[cited 2023 Nov 27]] doi:10.1126/scitranslmed.3000322.
   PubMed Web of Science ®Google Scholar
• Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT. et al. Human genetics shape the gut microbiome. Cell. 2014;159(4):789–799. doi:10.1016/j.cell.2014.09.053.
   PubMed Web of Science ®Google Scholar
• Zhang L, Bahl MI, Roager HM, Fonvig CE, Hellgren LI, Frandsen HL, Pedersen O, Holm J-C, Hansen T, Licht TR. Environmental spread of microbes impacts the development of metabolic phenotypes in mice transplanted with microbial communities from humans. ISME J. 2017;11(3):676–690. doi:10.1038/ismej.2016.151.
   PubMed Web of Science ®Google Scholar
• Griffin NW, Ahern PP, Cheng J, Heath AC, Ilkayeva O, Newgard CB, Fontana L, Gordon JI. Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host & Microbe. 2017;21(1):84–96. doi:10.1016/j.chom.2016.12.006.
   PubMed Web of Science ®Google Scholar
• Planer JD, Peng Y, Kau AL, Blanton LV, Ndao IM, Tarr PI, Warner BB, Gordon JI. Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice. Nature. 2016;534(7606):263–266. doi:10.1038/nature17940.
   PubMed Web of Science ®Google Scholar
• Van Den Ham KM, Little MR, Bednarski OJ, Fusco EM, Mandal RK, Mitra R, Li S, Doumbo S, Doumtabe D, Kayentao K. et al. Creation of a non-Western humanized gnotobiotic mouse model through the transplantation of rural African fecal microbiota. Microbiol Spectr. 2023;11(6):e01554–23. doi:10.1128/spectrum.01554-23.
   PubMedGoogle Scholar
• Wang Y, Zhang Z, Liu B, Zhang C, Zhao J, Li X, Chen L. A study on the method and effect of the construction of a humanized mouse model of fecal microbiota transplantation. Front Microbiol. 2022;13:1031758. doi:10.3389/fmicb.2022.1031758.
   PubMed Web of Science ®Google Scholar
• Hutchison ER, Kasahara K, Zhang Q, Vivas EI, Cross T-W, Rey FE. Dissecting the impact of dietary fiber type on atherosclerosis in mice colonized with different gut microbial communities. NPJ Biofilms Microbio. 2023;9(1):31. doi:10.1038/s41522-023-00402-7.
   PubMed Web of Science ®Google Scholar
• Li Y, Cao W, Gao NL, Zhao X-M, Chen W-H. Consistent alterations of human fecal microbes after transplantation into germ-free mice. Genomics, Proteomics & Bioinformatics. 2022;20(2):382–393. doi:10.1016/j.gpb.2020.06.024.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhao J, Zhang H, Zhai Q, Chen W. Mining Lactobacillus and Bifidobacterium for organisms with long-term gut colonization potential. Clin Nutr. 2020;39(5):1315–1323. doi:10.1016/j.clnu.2019.05.014.
   PubMed Web of Science ®Google Scholar
• Caballero S, Kim S, Carter RA, Leiner IM, Sušac B, Miller L, Kim GJ, Ling L, Pamer EG. Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell Host & Microbe. 2017;21(5):592–602.e4. doi:10.1016/j.chom.2017.04.002.
   PubMed Web of Science ®Google Scholar
• Davis LMG, Martínez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol. 2010;144(2):285–292. doi:10.1016/j.ijfoodmicro.2010.10.007.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Li Z, Summanen PH, Downes J, Thames G, Corbett K, Dowd S, Krak M, Heber D. Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food Funct. 2014;5(3):436. doi:10.1039/c3fo60348b.
   PubMed Web of Science ®Google Scholar
• Tandon D, Haque MM, Gote M, Jain M, Bhaduri A, Dubey AK, Mande SS. A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci Rep. 2019;9(1):5473. doi:10.1038/s41598-019-41837-3.
   PubMedGoogle Scholar
• Costabile A, Deaville ER, Morales AM, Gibson GR, Riedel CU. Prebiotic potential of a maize-based soluble fibre and impact of dose on the human gut microbiota. PloS ONE. 2016;11(1):e0144457. doi:10.1371/journal.pone.0144457.
   PubMed Web of Science ®Google Scholar
• Tran TTT, Cousin FJ, Lynch DB, Menon R, Brulc J, Brown J-M, O’Herlihy E, Butto LF, Power K, Jeffery IB. et al. Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity. Microbiome. 2019;7(1):39. doi:10.1186/s40168-019-0654-1.
   PubMedGoogle Scholar
• Cui S, Gu J, Liu X, Li D, Mao B, Zhang H, Zhao J, Chen W. Lactulose significantly increased the relative abundance of Bifidobacterium and Blautia in mice feces as revealed by 16S rRNA amplicon sequencing. J Sci Food Agric. 2021;101(13):5721–5729. doi:10.1002/jsfa.11181.
   PubMed Web of Science ®Google Scholar
• Wang L, Hu L, Yan S, Jiang T, Fang S, Wang G, Zhao J, Zhang H, Chen W. Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation. Food Funct. 2017;8(5):1966–1978. doi:10.1039/C7FO00031F.
   PubMed Web of Science ®Google Scholar
• Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem. 2011;286(40):34583–34592. doi:10.1074/jbc.M111.248138.
   PubMed Web of Science ®Google Scholar
• Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, Lebrilla CB, Mills DA. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem. 2010;58(9):5334–5340. doi:10.1021/jf9044205.
   PubMed Web of Science ®Google Scholar
• Bajic D, Wiens F, Wintergerst E, Deyaert S, Baudot A, Van Den Abbeele P. HMOs exert marked bifidogenic effects on children’s gut microbiota ex vivo, due to age-related Bifidobacterium species composition. Nutrients. 2023;15(7):1701. doi:10.3390/nu15071701.
   PubMed Web of Science ®Google Scholar
• Yu Z-T, Chen C, Newburg DS. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology. 2013;23(11):1281–1292. doi:10.1093/glycob/cwt065.
   PubMed Web of Science ®Google Scholar
• Walter J, Maldonado-Gómez MX, Martínez I. To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes. Curr Opin Biotechnol. 2018;49:129–139. doi:10.1016/j.copbio.2017.08.008.
   PubMed Web of Science ®Google Scholar
• Cantu-Jungles TM, Hamaker BR. Erratum for Cantu-Jungles and Hamaker, “New view on dietary fiber selection for predictable shifts in gut microbiota”. mBio. 2020;11(3):e02179–19. doi:10.1128/mBio.00747-20.
   PubMed Web of Science ®Google Scholar
• Patnode ML, Beller ZW, Han ND, Cheng J, Peters SL, Terrapon N, Henrissat B, Le Gall S, Saulnier L, Hayashi DK. et al. Interspecies competition impacts targeted manipulation of human gut bacteria by fiber-derived glycans. Cell. 2019;179(1):59–73.e13. doi:10.1016/j.cell.2019.08.011.
   PubMed Web of Science ®Google Scholar
• Shepherd ES, DeLoache WC, Pruss KM, Whitaker WR, Sonnenburg JL. An exclusive metabolic niche enables strain engraftment in the gut microbiota. Nature. 2018;557(7705):434–438. doi:10.1038/s41586-018-0092-4.
   PubMed Web of Science ®Google Scholar
• Cantu-Jungles TM, Bulut N, Chambry E, Ruthes A, Iacomini M, Keshavarzian A, Johnson TA, Hamaker BR, Zambrano MM. Dietary fiber hierarchical specificity: the missing link for predictable and strong shifts in gut bacterial communities. mBio. 2021;12(3):e01028–21. doi:10.1128/mBio.01028-21.
   PubMed Web of Science ®Google Scholar
• van Lingen E, Terveer EM, van der Meulen-de Jong AE, Vendrik KEW, Verspaget HW, Kuijper EJ, Kassam Z, Keller JJ. Advances in stool banking. Microbiota In Health And Disease [Internet]. [cited 2023 Nov 30]; 2020; 2. 10.26355/mhd_20201_182. Available from
   Google Scholar
• Cui B, Li P, Xu L, Peng Z, Zhao Y, Wang H, He Z, Zhang T, Ji G, Wu K. et al. Fecal microbiota transplantation is an effective rescue therapy for refractory inflammatory bowel disease. Inflamm Cell Signal. 2015;2:e757.
   Google Scholar
• Varga A, Kocsis B, Sipos D, Kása P, Vigvári S, Pál S, Dembrovszky F, Farkas K, Péterfi Z. How to apply FMT more effectively, conveniently and flexible – a comparison of FMT methods. Front Cell Infect Microbiol. 2021;11:657320. doi:10.3389/fcimb.2021.657320.
   PubMed Web of Science ®Google Scholar
• Halkjær SI, Christensen AH, BZS L, Browne PD, Günther S, Hansen LH, Petersen AM. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018;67(12):2107–2115. doi:10.1136/gutjnl-2018-316434.
   PubMed Web of Science ®Google Scholar
• Lee P-C, Chang T-E, Wang Y-P, Lee K-C, Lin Y-T, Chiou J-J, Huang C-W, Yang U-C, Li F-Y, Huang H-C. et al. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. J Formos Med Assoc. 2022;121(9):1636–1646. doi:10.1016/j.jfma.2021.11.001.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232–236. doi:10.1038/nature12331.
   PubMed Web of Science ®Google Scholar
• Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, Desai P, Lebrilla CB, Weimer BC, Mills DA, German JB. et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host & Microbe. 2011;10(5):507–514. doi:10.1016/j.chom.2011.10.007.
   PubMed Web of Science ®Google Scholar
• NCSS. PASS 2023 power analysis and sample size software [Internet]. 2023; Available from: ncss.com/software/pass
   Google Scholar
• Furet J-P, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Doré J, Corthier G. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR: human and farm animal faecal microbiota. FEMS Microbiol Ecol. 2009;68(3):351–362. doi:10.1111/j.1574-6941.2009.00671.x.
   PubMed Web of Science ®Google Scholar
• Han J, Lin K, Sequeira C, Borchers CH. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography–tandem mass spectrometry. Anal Chim Acta. 2015;854:86–94. doi:10.1016/j.aca.2014.11.015.
   PubMed Web of Science ®Google Scholar
• Xu L, Spink DC. Analysis of steroidal estrogens as pyridine-3-sulfonyl derivatives by liquid chromatography electrospray tandem mass spectrometry. Anal Biochem. 2008;375(1):105–114. doi:10.1016/j.ab.2007.11.028.
   PubMed Web of Science ®Google Scholar